New Fashion Design for Glatiramer - GnRH Antagonist Used for Peptides Synthesis – Gentolex

Short Description:

Send email to us

Product Detail

Product Tags

Feedback (2)

To create far more benefit for customers is our company philosophy; customer growing is our working chase for Cas No 2393-23-9, Diethylene Glycol Dibenzoate 120-55-8, Tadaldfil, We cordially welcome shoppers from in the home and overseas to hitch us and cooperate with us to enjoy a better future.

New Fashion Design for Glatiramer - GnRH Antagonist Used for Peptides Synthesis – Gentolex Detail:

Product Detail

NO	Products	CAS No.	Application	Key Quality Indicator
NO	Products	CAS No.	Application	Purity	Isomer	Specific impurity	*Max1	Moisture
1	Fmoc-3-(2-naphthyl)-D-Ala-OH	138774-94-4	Most products	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
2	Ac-3-(2-naphthyl)-D-Ala-OH	37440-01-0	Most products	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
3	Fmoc-3-(3-pyridinyl)-D-Ala-OH	142994-45-4	Most products	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
4	Fmoc-4-chloro-D-Phe-OH	142994-19-2	Most products	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
5	Fmoc-D-Cit-OH	200344-33-8	Cetrorelix	≥99.5%	≤0.1%	≤0.1%	≤0.2%	≤1.0%
6	Fmoc-D-Ala-OH.H2O	79990-15-1	Most products	≥99.5%	≤0.1%	≤0.1%	≤0.2%	≤6.5%
7	Fmoc-D-Aph(tBuCbm)-OH	1433975-21-3	Degarelix	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
8	Fmoc-D-Aph(Cbm)-OH	324017-22-3	Degarelix	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
9	Fmoc-L-Aph(L-Hor)-OH	1253282-31-3	Degarelix	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
10	Fmoc-L-Lys(iPr,Boc)-OH	201003-48-7	Degarelix Abarelix Antide	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
11	Fmoc-N-Me-Tyr(tBu)-OH	133373-24-7	Abarelix	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
12	Fmoc-D-Asn(Trt)-OH	180570-71-2	Abarelix	≥99.0%	≤0.2%	≤0.3%	≤0.3%	≤1.0%
13	Fmoc-HomoArg(Et)2-OH.HCl	1864003-26-8	Ganirelix	≥95.0%	≤0.5%	≤1.0%	≤2.0%	≤2.0%
14	Fmoc-D-HomoArg(Et)2-OH.HCl	2098497-24-4	Ganirelix	≥95.0%	≤0.5%	≤1.0%	≤2.0%	≤2.0%
15	Fmoc-Lys(nicotinoyl)-OH	252049-11-9	Antide	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%
16	Fmoc-D-Lys(nicotinoyl)-OH	252049-12-0	Antide	≥98.0%	≤0.2%	≤0.3%	≤0.5%	≤1.0%

* Max1 = Max Unknown Impurity

Other Indicator:

- Acetic Acid: ≤0.02% (All Products)

- Ethyl Acetate: ≤0.5% (All Products)

- Alcohol: ≤0.5% (All Products)

TOC and Conductivity

TOC and conductivity of main supply and return points are monitored periodically. TOC is monitored by QC on every week. Conductivity is monitored online and recorded by purified water station operator once every four hours. The conductivity is monitored at the primary RO, secondary RO, EDI and total return point of distribution system. The specification of purified water is in place and conforms to pre-defined specification which no more than 1.3 µs/cm at 25°C (USP). For main supply and return points, full test. is performed every week, for other using point in the circulating loop, full test is performed once every month. The full test includes characters, pH, nitrate, nitrite, ammonia, conductivity, TOC, non-volatile substances, heavy metals, microbial limits and bacterial endotoxin.

Product detail pictures:

Related Product Guide:

We not only will try our best to offer excellent services to every customer, but also are ready to receive any suggestion offered by our customers for New Fashion Design for Glatiramer - GnRH Antagonist Used for Peptides Synthesis – Gentolex , The product will supply to all over the world, such as: America, Danish, panama, We seriously promise that we provide all the customers with the best quality products, the most competitive prices and the most prompt delivery. We hope to win a resplendent future for customers and ourselves.

20 Standard Amino Acids

Acetyl Carnitine Powder

Avanafil

Diethyl Maleate

L-Malate Sodium

L-Malic Acid

Liquid Amino Acids

Sodium(+)-10-Camphorsulfonate

Tianeptine Sodium Salt

Vancomycin 1.5 G

Customer service staff and sales man are very patience and they all good at English, product's arrival is also very timely, a good supplier.

By Nancy from Angola - 2017.02.28 14:19

Hope that the company could stick to the enterprise spirit of "Quality, Efficiency, Innovation and Integrity", it will be better and better in the future.

By Christopher Mabey from Grenada - 2017.06.16 18:23

Write your message here and send it to us